(-0.68%) 5 081.60 points
(-0.81%) 38 073 points
(-0.81%) 15 854 points
(-1.08%) $81.74
(-0.69%) $2.02
(-2.10%) $2 308.20
(-3.51%) $26.69
(-1.85%) $943.70
(0.41%) $0.936
(0.93%) $11.08
(0.41%) $0.799
(0.26%) $93.55
-0.21% $ 0.433
@ $0.562
Emitido: 12 feb 2024 @ 11:22
Retorno: -22.94%
Señal anterior: feb 7 - 11:41
Señal anterior:
Retorno: 4.13 %
Live Chart Being Loaded With Signals
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults...
Stats | |
---|---|
Volumen de hoy | 52 623.00 |
Volumen promedio | 588 948 |
Capitalización de mercado | 12.86M |
EPS | $-22.40 ( 2024-03-10 ) |
Próxima fecha de ganancias | ( $0 ) 2024-06-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0.110 |
ATR14 | $0.00200 (0.46%) |
Volumen Correlación
Redhill Biopharma Ltd Correlación
10 Correlaciones Más Positivas | |
---|---|
TTCF | 0.968 |
LNSR | 0.963 |
VIRX | 0.961 |
WISA | 0.959 |
IMRX | 0.957 |
NOTV | 0.956 |
IMCC | 0.955 |
SRZN | 0.955 |
SNCE | 0.954 |
FATE | 0.95 |
10 Correlaciones Más Negativas | |
---|---|
MGI | -0.956 |
CCRC | -0.944 |
PWOD | -0.942 |
STIM | -0.937 |
NWFL | -0.935 |
IMMR | -0.933 |
ROST | -0.93 |
HZNP | -0.929 |
ACAHU | -0.924 |
EWEB | -0.924 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Redhill Biopharma Ltd Correlación - Moneda/Commodity
Redhill Biopharma Ltd Finanzas
Annual | 2023 |
Ingresos: | $6.51M |
Beneficio Bruto: | $3.06M (47.03 %) |
EPS: | $3.68 |
FY | 2023 |
Ingresos: | $6.51M |
Beneficio Bruto: | $3.06M (47.03 %) |
EPS: | $3.68 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Ingresos: | $61.80M |
Beneficio Bruto: | $28.46M (46.06 %) |
EPS: | $-38.27 |
Financial Reports:
No articles found.
Redhill Biopharma Ltd
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico